retatrutide how to get is one of the most exciting medications currently being studied for obesity and metabolic Retatrutide for Weight Loss: What

More research is needed to study potential short- and long-term risks across a broader population, which is why GLP-1s are generally not recommended for breastfeeding women

Plenty of evidence shows that GLP-1 medications can help people manage type 2 diabetes and/or obesity

Through June 2026, Medicare does not cover Wegovy or Zepbound for weight loss

Their analysis encompassed 15 unique RCTs, involving a total of 652 patients

Gehart H, van Es JH, Hamer K, Beumer J, Kretzschmar K, Dekkers JF, et al

Legal Filings and Motions to Dismiss: Novo Nordisk has actively filed motions to dismiss various lawsuits, arguing that plaintiffs have not provided sufficient evidence to link their conditions directly to Ozempic